跳至主要内容
临床试验/IRCT20220702055337N1
IRCT20220702055337N1招募中3 期

The effect of amikacin in the prevention of ventilator-induced pneumonia in patients admitted IC

Arak University of Medical Sciences0 个研究点目标入组 126 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age 18 and above
  • Absence of lung disease and lung mass
  • No use of chemotherapy drugs
  • Absence of intestinal nutrition
  • No receiving of Antibiotics before the onset of VAP
  • Absence of kidney disease and chronic kidney failure with basic glomerular filtration less than 30 ml in minutes
  • No removing the patient's tracheal tube within the next 48 hours after insertion
  • Lack of sensitivity to amikacin
  • Absence of Myasthenia gravis
  • Not pregnant or Lactating
  • Absence of covid-19 disease (negative PCR)
  • GFR more than 50

排除标准

  • 未提供

研究者

相似试验